Takahashi S, Godse D D, Naqvi A, Warsh J J, Stancer H C
Clin Chim Acta. 1978 Mar 1;84(1-2):55-62. doi: 10.1016/0009-8981(78)90476-x.
Procedures for the quantification of 5-hydroxyindole-3-ethanol, or 5-hydroxy-tryptophol (5-HTOL), in human cerebrospinal fluid are described. 5-HTOL was determined as its di-pentafluorpropionyl derivative. Deuterium labelled 5-hydroxyindole-3-ethanol-a,a,b,b-d4 (5-HTOL-d4) was used as internal standard. Mass fragmentography was performed by double ion monitoring each for 5-HTOL and 5-HTOL-d4 and their ratios were determined for specificity. Assay sensitivities of 0.15 ng/ml were achieved using 2.0 ml of cerebrospinal fluid. Free 5-HTOL concentrations in human cerebrospinal fluid were determined to be 0.73 +/- 0.44 ng/ml (mean +/- S.D.) (range 0.33-2.11 ng/ml) from 15 patients with various neurological disorders, and 0.85 +/- 0.30 ng/ml (range 0.48-1.32 ng/ml) from 9 subjects who complained of low back pain but did not show signs of neurological illnesses.
本文描述了定量检测人脑脊液中5-羟吲哚-3-乙醇(5-hydroxyindole-3-ethanol,5-HTOL)的方法。5-HTOL以其二-五氟丙酰基衍生物形式进行测定。氘代标记的5-羟吲哚-3-乙醇-a,a,b,b-d4(5-HTOL-d4)用作内标。通过对5-HTOL和5-HTOL-d4进行双离子监测来进行质量碎片分析,并测定它们的比率以确保特异性。使用2.0 ml脑脊液时,检测灵敏度达到0.15 ng/ml。对15例患有各种神经系统疾病的患者进行检测,结果显示人脑脊液中游离5-HTOL浓度为0.73±0.44 ng/ml(平均值±标准差)(范围为0.33 - 2.11 ng/ml);对9例主诉腰痛但未表现出神经系统疾病体征的受试者进行检测,其脑脊液中游离5-HTOL浓度为0.85±0.30 ng/ml(范围为0.48 - 1.32 ng/ml)。